Solid Biosciences (SLDB) Cash & Current Investments: 2017-2024
Historic Cash & Current Investments for Solid Biosciences (SLDB) over the last 8 years, with Sep 2024 value amounting to $171.1 million.
- Solid Biosciences' Cash & Current Investments rose 19.76% to $171.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $691.1 million, marking a year-over-year decrease of 1.60%. This contributed to the annual value of $123.6 million for FY2023, which is 42.15% down from last year.
- Latest data reveals that Solid Biosciences reported Cash & Current Investments of $171.1 million as of Q3 2024, which was down 10.06% from $190.3 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Cash & Current Investments registered a high of $268.5 million during Q1 2021, and its lowest value of $24.8 million during Q3 2020.
- Over the past 3 years, Solid Biosciences' median Cash & Current Investments value was $171.1 million (recorded in 2024), while the average stood at $170.8 million.
- As far as peak fluctuations go, Solid Biosciences' Cash & Current Investments tumbled by 76.53% in 2020, and later spiked by 401.05% in 2021.
- Over the past 5 years, Solid Biosciences' Cash & Current Investments (Quarterly) stood at $154.7 million in 2020, then soared by 34.27% to $207.8 million in 2021, then rose by 2.86% to $213.7 million in 2022, then crashed by 42.15% to $123.6 million in 2023, then grew by 19.76% to $171.1 million in 2024.
- Its last three reported values are $171.1 million in Q3 2024, $190.3 million for Q2 2024, and $206.1 million during Q1 2024.